List

Equity Risk Partners Leads Insurance Due Diligence for Gryphon Investors' Acquisition of Hepaco

Healthcare and Life Sciences

Company: HEPACO (www.hepaco.com) is a leading provider of emergency response, environmental remediation, maritime services, wastewater treatment, and other industrial services across a diversified group of end markets including rail, oil & gas, transportation, power & utility, and manufacturing. The Company has a broad geographic footprint across 20 states in the Mid-Atlantic and Southeast United States and offers a two-hour or less response time within its footprint. The Company provides services on both an emergency response and planned basis and completed more than 6,250 projects in 2015.

Investor: Based in San Francisco, Gryphon Investors (www.gryphoninvestors.com) is a leading private equity firm focused on profitably growing and competitively enhancing middle-market companies in partnership with experienced management. For four consecutive years, Gryphon has been ranked in Preqin’s prestigious quarterly PE report as one of North America’s top-decile firms based on consistency of strong investment returns. With over $2 billion of cumulative equity commitments, the firm has an extensive track record of leading equity investments of $35 million to $150 million per portfolio company with sales ranging from approximately $50 million to $500 million. Gryphon prioritizes investment opportunities where it can form proactive partnerships with owners and executives to build leading companies, utilizing Gryphon’s capital, specialized professional resources, and operational expertise.

If you would like more information please contact Michael Marcon at mmarcon@equityrisk.com or (415) 874-7101.